ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced that Adam Grossman, ADMA’s President, Chief Executive Officer and founder, is scheduled to present a company overview at the 13th Annual Needham Healthcare Conference on Wednesday, April 9, 2014, at 8:00 a.m. EDT. The conference will be held from April 8-9, 2014 at The Westin New York Grand Central Hotel, New York, NY.
Help employers find you! Check out all the jobs and post your resume.
